McDonnell, E. I., Xie, S., Marder, K., Cui, F., & Wang, Y. (2024). Dynamic undirected graphical models for time‐varying clinical symptom and neuroimaging networks. Statistics in Medicine, 43(21), 4131–4147. Portico. https://doi.org/10.1002/sim.10143

Paryani, F., Kwon, J.-S., Ng, C. W., Jakubiak, K., Madden, N., Ofori, K., Tang, A., Lu, H., Xia, S., Li, J., Mahajan, A., Davidson, S. M., Basile, A. O., McHugh, C., Vonsattel, J. P., Hickman, R., Zody, M. C., Housman, D. E., Goldman, J. E., … Al-Dalahmah, O. (2024). Multi-omic analysis of Huntington’s disease reveals a compensatory astrocyte state. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50626-0

Li, H., Desai, R., Quiles, N., Quinn, L., & Friel, C. (2024). Characterizing Heart Rate Variability Response to Maximal Exercise Testing in People with Huntington’s Disease. Journal of Huntington’s Disease, 13(1), 67–76. https://doi.org/10.3233/jhd-230593

Goldman, J. S., Uhlmann, W. R., Naini, A. B., Klitzman, R. L., & Marder, K. S. (2023). Genetic Testing of HTT Modifiers for Huntington’s Disease: Considerations for Clinical Guidelines. Movement Disorders, 38(12), 2151–2154. Portico. https://doi.org/10.1002/mds.29650

Shih, H.-J. S., Quinn, L., Morgan-Jones, P., Long, K., Schreier, A. R., & Friel, C. P. (2023). Wearable Activity Monitors to Support Physical Activity Interventions in Neurodegenerative Disease: A Feasibility Study. Neurodegenerative Disease Management, 13(3), 177–189. https://doi.org/10.2217/nmt-2022-0028

Song, S., Su, Z., Kon, N., Chu, B., Li, H., Jiang, X., Luo, J., Stockwell, B. R., & Gu, W. (2023). ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington’s disease. Genes & Development, 37(5–6), 204–217. https://doi.org/10.1101/gad.350211.122

Pepe, G., Capocci, L., Marracino, F., Realini, N., Lenzi, P., Martinello, K., Bovier, T. F., Bichell, T. J., Scarselli, P., Di Cicco, C., Bowman, A. B., Digilio, F. A., Fucile, S., Fornai, F., Armirotti, A., Parlato, R., Di Pardo, A., & Maglione, V. (2023). Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease. Molecular Therapy, 31(1), 282–299. https://doi.org/10.1016/j.ymthe.2022.09.004

Lim, R. G., Al-Dalahmah, O., Wu, J., Gold, M. P., Reidling, J. C., Tang, G., Adam, M., Dansu, D. K., Park, H.-J., Casaccia, P., Miramontes, R., Reyes-Ortiz, A. M., Lau, A., Hickman, R. A., Khan, F., Paryani, F., Tang, A., Ofori, K., Miyoshi, E., … Thompson, L. M. (2022). Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-35388-x

Hickman, R. A., Faust, P. L., Marder, K., Yamamoto, A., & Vonsattel, J.-P. (2022). The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade. Acta Neuropathologica Communications, 10(1). https://doi.org/10.1186/s40478-022-01364-1

Crotty, G. F., Keavney, J. L., Alcalay, R. N., Marek, K., Marshall, G. A., Rosas, H. D., & Schwarzschild, M. A. (2022). Planning for Prevention of Parkinson Disease. Neurology, 99(7_Supplement_1), 1–9. https://doi.org/10.1212/wnl.0000000000200789

Quinn, L., Playle, R., Drew, C. J. G., Taiyari, K., Williams-Thomas, R., Muratori, L. M., Hamana, K., Griffin, B. A., Kelson, M., Schubert, R., Friel, C., Morgan-Jones, P., Rosser, A., Busse, M., Montojo, T., Ruiz Idiago, J. M., Hershberg, J., Marder, K., Bordelon, Y., … Landwehrmeyer, B. (2022). Physical activity and exercise outcomes in Huntington’s disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington’s disease. Parkinsonism & Related Disorders, 101, 75–89. https://doi.org/10.1016/j.parkreldis.2022.06.013

Fritz, N. E., Busse, M., Muratori, L. M., Rao, A. K., Kloos, A., Kegelmeyer, D., & Quinn, L. (2022). An MDS Evidence‐Based Review on Treatments for Huntington’s Disease. Movement Disorders, 37(7), 1566–1567. Portico. https://doi.org/10.1002/mds.29059

Xie, S., McDonnell, E., & Wang, Y. (2021). Conditional Gaussian graphical model for estimating personalized disease symptom networks. Statistics in Medicine, 41(3), 543–553. Portico. https://doi.org/10.1002/sim.9274